THE PROGNOSTIC ROLE OF THE ELF TEST, COMPARED TO LIVER BIOPSY, IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

被引：0
|
作者：
Liguori, A. [1 ]
D'Ambrosio, F. [2 ]
Nicholas, V. [1 ]
Termite, F. [1 ]
Petrucci, L. [1 ]
Beschi, R. [1 ]
Orienti, M. [2 ]
Galletti, S. [2 ]
Cardinali, S. [2 ]
Riccardi, L. [1 ]
Pizzolante, F. [1 ]
De, Matthaeis N. [1 ]
Zocco, M. A. [1 ]
Giustiniani, M. C. [3 ]
Marrone, G. [1 ]
Biolato, M. [1 ]
Cefalo, C. [1 ]
Vecchio, F. M. [3 ]
Pompili, M. [1 ]
Rapaccini, G. L. [1 ]
Grieco, A. [1 ]
Urbani, A. [2 ]
Sanguinetti, M. [2 ]
Gasbarrini, A. [1 ]
Miele, L. [1 ]
机构：
[1] Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Traslat Med & Surg, Rome, Italy
[2] Fdn Policlin Univ A Gemelli IRCCS, Dept Lab & Infect Sci, Rome, Italy
[3] Fdn Policlin Univ A Gemelli IRCCS, Dept Women Children & Publ Hlth Sci, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2024年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T.07.5
引用
收藏
页码：S257 / S257
页数：1
相关论文
共 50 条
  • [21] INSULIN RESISTANCE IS A PREDICTOR OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) AND MASLD-ASSOCIATED FIBROSIS
    Kim, David S.
    Ismail, Mohamed
    Abboud, Yazan
    Khan, Wajiha
    Le, Alexander
    Pyrsopoulos, Nikolaos T.
    Kim, Hyunseok
    Hajifathalian, Kaveh
    GASTROENTEROLOGY, 2024, 166 (05) : S1657 - S1657
  • [22] Evaluation of a Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Clinical Pharmacy Service
    Sallam, Sandy
    Ahmed, Aijaz
    Gu, Xin
    DIABETES, 2024, 73
  • [23] ALTERED GUT VIRAL ECOLOGY IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Nzabarushimana, Etienne
    Kim, Hanseul
    Jensen, Jordan
    Shen, Jiaxian
    Nelson, Paul
    Thompson, Kelsey N.
    Chan, Andrew T.
    Hayete, Boris
    Huttenhower, Curtis
    Nguyen, Long H.
    GASTROENTEROLOGY, 2024, 166 (05) : S1539 - S1540
  • [24] Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD)
    van Son, Koen C.
    van Dijk, Anne-Marieke
    Driessen, Stan
    Mak, Anne Linde
    Witjes, Julia J.
    Houttu, Veera A. T.
    Zwirs, Diona
    Nieuwdorp, Max
    van den Born, Bert-Jan H.
    Fischer, Johan C.
    Tushuizen, Maarten E.
    Drenth, Joost P. H.
    Hamer, Henrike M.
    Beuers, Ulrich H. W.
    Verheij, Joanne
    Holleboom, Adriaan Georgius
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2024, 62 (11) : e236 - e239
  • [25] Epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD)
    Wong, Robert J.
    METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (04):
  • [26] Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Zazueta, Alejandra
    Valenzuela-Perez, Lucia
    Ortiz-Lopez, Nicolas
    Pinto-Leon, Araceli
    Torres, Veronica
    Guinez, Danette
    Aliaga, Nicolas
    Merino, Pablo
    Sandoval, Alexandra
    Covarrubias, Natalia
    Perez de Arce, Edith
    Cattaneo, Maximo
    Urzua, Alvaro
    Roblero, Juan Pablo
    Poniachik, Jaime
    Gotteland, Martin
    Magne, Fabien
    Beltran, Caroll Jenny
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (08)
  • [27] Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
    Nakamura, Toru
    Masuda, Atsutaka
    Nakano, Dan
    Amano, Keisuke
    Sano, Tomoya
    Nakano, Masahito
    Kawaguchi, Takumi
    CELLS, 2025, 14 (06)
  • [28] Subclinical myocardial fibrosis is related to disease severity in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
    Nabilou, Puria
    Wiese, Signe
    Hetland, Liv
    Werge, Mikkel
    Thing, Mira
    Rashu, Elias
    Junker, Anders
    Barlose, Mads
    Siebner, Hartwig
    Moller, Soren
    Bendtsen, Flemming
    Gluud, Lise Lotte
    Hove, Jens
    JOURNAL OF HEPATOLOGY, 2024, 80 : S555 - S555
  • [29] Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Ramanathan, Raghu
    Patwa, Sohum A.
    Ali, Ahmad Hassan
    Ibdah, Jamal A.
    CELLS, 2023, 12 (24)
  • [30] Metabolic dysfunction-associated steatotic liver disease and the heart
    Driessen, Stan
    Francque, Sven M.
    Anker, Stefan D.
    Cabezas, Manuel Castro
    Grobbee, Diederick E.
    Tushuizen, Maarten E.
    Holleboom, Adriaan G.
    HEPATOLOGY, 2023,
12345